Supported by our experiences and capabilities, we arethe leader in the field of bioavailability and bioequivalence (BA/BE) studies and clinical trial services inIndonesia and Southeast Asia.
Established in 2003 as the first independent Bioequivalence Center in Indonesia, Equilab International has been providing our service for local and international pharma company in Asia, Australia, America, Africa, and Europe.